Biofidelity has developed molecular biology technologies, Aspyre® and Enspyre®, that enable local and cost-effective genomic analysis for cancer diagnosis and treatment selection. This approach addresses the challenge of limited access to biomarker testing, ensuring more patients receive timely and appropriate targeted therapies.

Caristo Diagnostics utilizes CaRi-Heart® technology to detect hidden inflammation in coronary arteries, enabling early diagnosis of heart diseases, stroke, and diabetes. This platform enhances preventive screening and optimizes treatment planning by providing individualized risk scores based on advanced imaging analysis.

Closed Loop Medicine develops personalized digital healthcare solutions that integrate dose-optimized drug therapy with digital therapeutics to enhance treatment adherence and patient outcomes. The platform addresses the inefficiencies of traditional healthcare delivery, which often leads to suboptimal management of chronic conditions and increased costs for payors.

Engine is a travel management platform that consolidates booking and invoicing for business trips, allowing companies to manage all travel-related expenses in one dashboard. By eliminating agent-assist fees and providing a virtual credit card for incidentals, Engine helps businesses save time and reduce travel costs without any membership fees or contracts.

Helio Display Materials develops perovskite-based color conversion materials for display technologies, enhancing color accuracy and efficiency in micro displays. By leveraging proprietary intellectual property from leading researchers, Helio aims to replace traditional quantum dot materials, addressing limitations in color performance and production scalability.

The startup develops a decentralized platform that provides point-to-point quantum-resistant authentication for various operating systems and IoT stacks. This technology enables network providers to implement a secure and scalable authentication service for sensor networks and complex IoT systems, enhancing data integrity and user trust.

Kinomica utilizes phosphoproteomics through its KScan® diagnostic platform to enhance cancer treatment selection by identifying the most effective therapies for individual patients. This approach provides critical insights into protein activation and signaling pathways, enabling the development of targeted therapies and improved patient outcomes.

The startup develops modular aeroponic irrigation systems that utilize intelligent control technology to enhance the efficiency of indoor farming. Their nozzle-free, fully automatable systems eliminate the need for pesticides, significantly lowering operational costs and reducing the carbon footprint associated with fresh produce cultivation.

The startup has developed a microfluidic technology that manipulates individual droplets containing cells, enabling precise detection and automatic counting of cells within each droplet. This technology facilitates massively parallel assays with multiple readouts, allowing healthcare clients to efficiently manage complex workflows while preserving cell viability in targeted droplets.

The startup operates a cell therapy research and manufacturing platform that enhances process control and scalability in autologous cell and gene therapy bioprocessing. By enabling parallel execution of cell culture conditions, the platform reduces manufacturing costs while improving efficiency in process development.

Mirico develops Laser Dispersion Spectroscopy (LDS) technology for precise gas measurement, enabling real-time monitoring of greenhouse gas emissions, fugitive emissions, and agricultural pollutants. This technology provides accurate data to support environmental compliance and sustainability efforts in the oil and gas, agricultural, and environmental science sectors.

The startup develops injectable bio-structural gel implants that are administered into the nucleus of intervertebral discs to restore mechanical function and alleviate back pain. This micro-invasive procedure, completed in under 30 minutes, creates a supportive scaffold that suppresses degenerative processes in spinal discs.

Oxford PV develops perovskite-on-silicon tandem solar cells that significantly increase energy conversion efficiency beyond conventional silicon limits. This technology integrates with existing manufacturing processes to deliver higher power output per area, reducing the levelized cost of energy for solar installations.

The startup manufactures metal additive manufacturing machines that enable the use of super hard-wearing and high-temperature materials for 3D printing. This technology enhances precision and complexity in applications across aerospace, medical, energy, and tooling industries, where traditional methods are insufficient.